Infliximab is a plausible alternative for neurologic complications of Behçet disease

OBJECTIVE: We evaluated the effectiveness of infliximab in patients with neuro-Behçet syndrome for whom other immunosuppressive medications had failed. METHODS: Patients whose common immunosuppressive medications fail in recurrent neuro-Behçet syndrome need an alternative. We report our experience w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Neuroimmunol Neuroinflamm
Autors principals: Zeydan, Burcu, Uygunoglu, Ugur, Saip, Sabahattin, Demirci, Onat N., Seyahi, Emire, Ugurlu, Serdal, Hamuryudan, Vedat, Siva, Aksel, Kantarci, Orhun H.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950829/
https://ncbi.nlm.nih.gov/pubmed/27458602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000258
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars